Ganesh M Mugundu (Ganesh Mugundu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Papillary Thyroid

Top Venues

Journal of clinical pharmacology

Targeted oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Johnson, Daniel Kaschek, Dana Ghiorghiu, Shankar Lanke, Kowser Miah, Henning Schmidt, Ganesh M Mugundu
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors. Journal of clinical pharmacology (2024)
Todd M Bauer, Kathleen M Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Sarah A Cook, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Siqing Fu
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology (2023)
Mats Någård, Mei-Lin Ah-See, Karen So, Marit Vermunt, Fiona Thistlethwaite, Mariette Labots, Patricia Roxburgh, Alain Ravaud, Mario Campone, Liselot Valkenburg-van Iersel, Lone Ottesen, Yan Li, Ganesh M Mugundu
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 86 (1) (2020)
Mark Farha, Eric Masson, Helen Tomkinson, Ganesh M Mugundu
Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology. Journal of clinical pharmacology 59 (4) (2018)